INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 54 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,337,442 | +31.6% | 6,353,645 | 0.0% | 0.04% | 0.0% |
| Q1 2023 | $1,016,583 | -71.2% | 6,353,645 | 0.0% | 0.04% | -75.2% |
| Q4 2022 | $3,526,273 | -53.4% | 6,353,645 | 0.0% | 0.15% | -52.2% |
| Q3 2022 | $7,561,000 | +88.2% | 6,353,645 | 0.0% | 0.31% | +60.8% |
| Q2 2022 | $4,017,000 | -44.5% | 6,353,645 | 0.0% | 0.19% | -33.1% |
| Q1 2022 | $7,243,000 | -49.3% | 6,353,645 | 0.0% | 0.29% | -44.1% |
| Q4 2021 | $14,296,000 | -50.1% | 6,353,645 | -24.2% | 0.52% | -53.6% |
| Q3 2021 | $28,672,000 | +14.4% | 8,383,645 | 0.0% | 1.12% | +19.2% |
| Q2 2021 | $25,067,000 | -7.4% | 8,383,645 | 0.0% | 0.94% | -7.5% |
| Q1 2021 | $27,079,000 | -26.7% | 8,383,645 | -51.9% | 1.02% | -30.1% |
| Q4 2020 | $36,945,000 | +81.2% | 17,426,968 | 0.0% | 1.45% | +30.9% |
| Q3 2020 | $20,390,000 | +29.3% | 17,426,968 | 0.0% | 1.11% | +14.2% |
| Q2 2020 | $15,764,000 | +8.0% | 17,426,968 | 0.0% | 0.97% | -28.6% |
| Q1 2020 | $14,599,000 | -12.7% | 17,426,968 | 0.0% | 1.36% | +7.3% |
| Q4 2019 | $16,730,000 | -6.8% | 17,426,968 | 0.0% | 1.27% | -32.8% |
| Q3 2019 | $17,950,000 | -42.8% | 17,426,968 | 0.0% | 1.89% | -45.0% |
| Q2 2019 | $31,369,000 | -4.3% | 17,426,968 | 0.0% | 3.43% | -6.6% |
| Q1 2019 | $32,763,000 | +59.3% | 17,426,968 | 0.0% | 3.67% | +36.5% |
| Q4 2018 | $20,564,000 | -50.2% | 17,426,968 | +14.4% | 2.69% | -25.9% |
| Q3 2018 | $41,279,000 | +41.9% | 15,232,268 | 0.0% | 3.63% | +27.7% |
| Q2 2018 | $29,094,000 | +41.9% | 15,232,268 | +56.0% | 2.84% | +36.6% |
| Q1 2018 | $20,510,000 | +3.5% | 9,766,508 | 0.0% | 2.08% | -13.0% |
| Q4 2017 | $19,826,000 | +89.5% | 9,766,508 | +24.2% | 2.39% | +79.7% |
| Q3 2017 | $10,462,000 | -15.3% | 7,866,108 | 0.0% | 1.33% | -30.7% |
| Q2 2017 | $12,350,000 | -51.4% | 7,866,108 | 0.0% | 1.92% | -55.6% |
| Q1 2017 | $25,408,000 | +139.4% | 7,866,108 | +0.1% | 4.32% | +102.7% |
| Q4 2016 | $10,612,000 | +32.1% | 7,860,808 | +52.6% | 2.13% | +40.8% |
| Q3 2016 | $8,033,000 | +16.5% | 5,149,644 | -0.7% | 1.51% | +3.1% |
| Q2 2016 | $6,896,000 | – | 5,184,600 | – | 1.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 6,353,645 | $4,017,000 | 0.19% |
| Gratus Capital, LLC | 1,117,154 | $706,000 | 0.08% |
| Bleichroeder LP | 250,000 | $158,000 | 0.03% |
| Polar Capital Holdings Plc | 5,000,000 | $3,162,000 | 0.02% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $345,000 | 0.01% |
| Ergoteles LLC | 419,652 | $265,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 249,000 | $157,000 | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 41,396 | $26,000 | 0.00% |
| Heritage Financial Services, LLC | 4,749 | $3,000 | 0.00% |
| Evercore Wealth Management, LLC | 143,138 | $91,000 | 0.00% |